Mavroudis D - Search Results

1

Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer.

Ignatiadis M, Xenidis N, Perraki M, Apostolaki S, Politaki E, Kafousi M, Stathopoulos EN, Stathopoulou A, Lianidou E, Chlouverakis G, Sotiriou C, Georgoulias V, Mavroudis D. Ignatiadis M, et al. Among authors: mavroudis d. J Clin Oncol. 2007 Nov 20;25(33):5194-202. doi: 10.1200/JCO.2007.11.7762. Epub 2007 Oct 22. J Clin Oncol. 2007. PMID: 17954712

2

A dose-escalation study of irinotecan (CPT-11) in combination with gemcitabine in patients with advanced non-small cell lung cancer previously treated with a cisplatin-based front line chemotherapy.

Kakolyris SS, Kouroussis C, Koukourakis M, Kalbakis K, Mavroudis D, Vardakis N, Georgoulias V. Kakolyris SS, et al. Among authors: mavroudis d. Anticancer Res. 2002 May-Jun;22(3):1891-6. Anticancer Res. 2002. PMID: 12168889 Clinical Trial.

3

Oxaliplatin with high-dose leucovorin and infusional 5-fluorouracil in irinotecan-pretreated patients with advanced colorectal cancer (ACC).

Kouroussis C, Souglakos J, Mavroudis D, Papadouris S, Kakolyris S, Agelaki S, Kalbakis K, Panopoulos C, Vardakis N, Sarra E, Georgoulias V. Kouroussis C, et al. Among authors: mavroudis d. Am J Clin Oncol. 2002 Dec;25(6):627-31. doi: 10.1097/00000421-200212000-00021. Am J Clin Oncol. 2002. PMID: 12478014 Clinical Trial.

4

A dose escalation study of docetaxel and oxaliplatin combination in patients with metastatic breast and non-small cell lung cancer.

Kouroussis C, Agelaki S, Mavroudis D, Kakolyris S, Androulakis N, Kalbakis K, Souglakos J, Mallas K, Bozionelou V, Pallis A, Adamtziki H, Georgoulias V. Kouroussis C, et al. Among authors: mavroudis d. Anticancer Res. 2003 Jan-Feb;23(1B):785-91. Anticancer Res. 2003. PMID: 12680184 Clinical Trial.

5

Real-time quantification of CK-19 mRNA-positive cells in peripheral blood of breast cancer patients using the lightcycler system.

Stathopoulou A, Gizi A, Perraki M, Apostolaki S, Malamos N, Mavroudis D, Georgoulias V, Lianidou ES. Stathopoulou A, et al. Among authors: mavroudis d. Clin Cancer Res. 2003 Nov 1;9(14):5145-51. Clin Cancer Res. 2003. PMID: 14613993

6

Assessment of highly angiogenic and disseminated in the peripheral blood disease in breast cancer patients predicts for resistance to adjuvant chemotherapy and early relapse.

Giatromanolaki A, Koukourakis MI, Kakolyris S, Mavroudis D, Kouroussis C, Mavroudi C, Perraki M, Sivridis E, Georgoulias V. Giatromanolaki A, et al. Among authors: mavroudis d. Int J Cancer. 2004 Feb 10;108(4):620-7. doi: 10.1002/ijc.11593. Int J Cancer. 2004. PMID: 14696130

7

High incidence of pulmonary toxicity of weekly docetaxel and gemcitabine in patients with non-small cell lung cancer: results of a dose-finding study.

Kouroussis C, Mavroudis D, Kakolyris S, Voloudaki A, Kalbakis K, Souglakos J, Agelaki S, Malas K, Bozionelou V, Georgoulias V. Kouroussis C, et al. Among authors: mavroudis d. Lung Cancer. 2004 Jun;44(3):363-8. doi: 10.1016/j.lungcan.2003.12.004. Lung Cancer. 2004. PMID: 15140550

8

Trastuzumab administration can effectively target chemotherapy-resistant cytokeratin-19 messenger RNA-positive tumor cells in the peripheral blood and bone marrow of patients with breast cancer.

Bozionellou V, Mavroudis D, Perraki M, Papadopoulos S, Apostolaki S, Stathopoulos E, Stathopoulou A, Lianidou E, Georgoulias V. Bozionellou V, et al. Among authors: mavroudis d. Clin Cancer Res. 2004 Dec 15;10(24):8185-94. doi: 10.1158/1078-0432.CCR-03-0094. Clin Cancer Res. 2004. PMID: 15623593

9

Sequential versus alternating administration of cisplatin/etoposide and topotecan as first-line treatment in extensive-stage small-cell lung cancer: preliminary results of a Phase III Trial of the Hellenic Oncology Research Group.

Ignatiadis M, Mavroudis D, Veslemes M, Boukovinas J, Syrigos K, Agelidou M, Agelidou A, Gerogianni A, Pavlakou G, Tselepatiotis E, Nikolakopoulos J, Georgoulias V. Ignatiadis M, et al. Among authors: mavroudis d. Clin Lung Cancer. 2005 Nov;7(3):183-9. doi: 10.3816/CLC.2005.n.034. Clin Lung Cancer. 2005. PMID: 16354313 Clinical Trial.

10

A highly specific real-time RT-PCR method for the quantitative determination of CK-19 mRNA positive cells in peripheral blood of patients with operable breast cancer.

Stathopoulou A, Ntoulia M, Perraki M, Apostolaki S, Mavroudis D, Malamos N, Georgoulias V, Lianidou ES. Stathopoulou A, et al. Among authors: mavroudis d. Int J Cancer. 2006 Oct 1;119(7):1654-9. doi: 10.1002/ijc.22017. Int J Cancer. 2006. PMID: 16708381

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

383 results

Search Page

Filters